Guaifenesin
Pricing Report NDC 63868-390-14

Latest NADAC: $0.46338 per EA · Effective Aug 17, 2022 · Est. package price $6.49 (14 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Guaifenesin Extended Release (NDC 63868-390-14) is $0.46338 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 17, 2022.

As a provided by Chain Drug Marketing Association Inc, this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.46338
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 17, 2022
Billable Units
14 EA
Estimated Package Price
$6.49
Data Status
As of Aug 17, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
63868-390-14
Description
1 BLISTER PACK in 1 CARTON / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.44980 to $0.47343 per EA. Over this 2 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4498 - $0.4734
Market Volatility
5.25% Variance
Latest Trend
0.57%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 17, 2022 $0.46338 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 20, 2022 $0.46602 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.46855 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $0.46382 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $0.46247 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $0.46517 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $0.45488 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $0.45112 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $0.46003 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $0.45095 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $0.45927 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $0.45982 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026